0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Could Magnesium Depletion Play a Role on Fracture Risk in PPI Users?

Gustavo Adolpho Moreira Faulhaber, MD, PhD; Tania Weber Furlanetto, MD, PhD
Arch Intern Med. 2010;170(19):1776. doi:10.1001/archinternmed.2010.374.
Text Size: A A A
Published online

Extract

We read with interest the study by Gray and colleagues1 about increased fracture risk among patients receiving PPIs without a significant change in bone mass density. The mechanism for this is unknown, but it could be related to hypomagnesemia. This condition has been recently described as an adverse effect of PPIs.2 It seems to be a class effect, since different PPIs induce this abnormality, and its mechanism is not fully understood but probably involves the intestinal absorption of magnesium.3 Magnesium has a close relation to bone metabolism. Its deficiency induces parathyroid dysfunction and hypoparathyroidism, which is a known risk factor for osteoporosis.4 An animal study has shown that hypomagnesemia decreases femur strength and the threshold for fracture with normal wet weights, diameters, and midfemoral cross-sectional areas.5 Rats with a magnesium-depleted diet develop bone loss, a decrease in osteoblasts, and an increase in osteoclasts by histomorphometry. These effects are observed even on mildly magnesium-restricted diets, which are not uncommon in humans.4 Further studies analyzing PPIs, bone density, and fracture risk should address hypomagnesemia as a possible associated factor.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 5

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Proton pump inhibitors: potential adverse effects. Curr Opin Gastroenterol 2012;28(6):615-20.
Jobs
JAMAevidence.com

Users' Guides to the Medical Literature
Clinical Resolution

Users' Guides to the Medical Literature
Clinical Scenario

brightcove.createExperiences();